Hsa-miR-139-5p is a prognostic thyroid cancer marker involved in HNRNPF-mediated alternative splicing.-论文-万方医学网

第一作者： Cristina,Montero-Conde

第一单位： Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.

作者： Cristina,Montero-Conde ^[1] ; Osvaldo,Graña-Castro ^[2] ; Guillermo,Martín-Serrano ^[2] ; Ángel M,Martínez-Montes ^[1] ; Eduardo,Zarzuela ^[3] ; Javier,Muñoz ^[3] ; Rafael,Torres-Perez ^[1] ; Guillermo,Pita ^[4] ; Alfonso,Cordero-Barreal ^[1] ; Luis J,Leandro-García ^[1] ; Rocío,Letón ^[1] ; Isabel,López de Silanes ^[5] ; Sonsoles,Guadalix ^[6] ; Andrés,Pérez-Barrios ^[7] ; Federico,Hawkins ^[6] ; Almudena,Guerrero-Álvarez ^[6] ; Cristina,Álvarez-Escolá ^[8] ; Rita M,Regojo-Zapata ^[9] ; Bruna,Calsina ^[1] ; Laura,Remacha ^[1] ; Juan M,Roldán-Romero ^[1] ; María,Santos ^[1] ; Javier,Lanillos ^[1] ; Mireia,Jordá ^[10] ; Garcilaso,Riesco-Eizaguirre ^[11] ; Carles,Zafon ^[12] ; Anna,González-Neira ^[4] ; Maria A,Blasco ^[5] ; Fátima,Al-Shahrour ^[2] ; Cristina,Rodríguez-Antona ^[1] ; Alberto,Cascón ^[1] ; Mercedes,Robledo ^[13]

作者单位： Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. ^[1] Bioinformatics Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. ^[2] Proteomics Core Unit and Proteored-ISCIII, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. ^[3] CEGEN Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. ^[4] Telomeres and Telomerase Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. ^[5] Endocrinology and Nutrition Department, Hospital Universitario 12 de Octubre, Madrid, Spain. ^[6] Anatomical Pathology Section, Hospital Universitario 12 de Octubre, Madrid, Spain. ^[7] Endocrinology and Nutrition Department, Madrid, Spain. ^[8] Anatomical Pathology Section Hospital Universitario La Paz, Madrid, Spain. ^[9] Program for Predictive and Personalized Medicine of Cancer, Germans Trias i Pujol Research Institute, Barcelona, Spain. ^[10] Endocrinology and Nutrition Department, Hospital Universitario de Móstoles, Madrid, Spain.;Biomedical Research Networking Centre in Oncology (CIBERONC), Institute of Health Carlos III, Madrid, Spain.;Universidad Francisco de Vitoria, Madrid, Spain. ^[11] Diabetes and Metabolism Research Unit and Endocrinology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.;Biomedical Research Networking Centre on Diabetes and Associated Metabolic Diseases (CIBERDEM), Institute of Health Carlos III, Madrid, Spain. ^[12] Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.;Biomedical Research Networking Centre on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain. ^[13]

医学主题词成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);选择性剪接(Alternative Splicing);细胞系, 肿瘤(Cell Line, Tumor);细胞增殖(Cell Proliferation);无病生存(Disease-Free Survival);女(雌)性(Female);随访研究(Follow-Up Studies);基因表达谱(Gene Expression Profiling);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);核不均一核糖核蛋白F-H组(Heterogeneous-Nuclear Ribonucleoprotein Group F-H);人类(Humans);Kaplan-Meiers评估(Kaplan-Meier Estimate);男(雄)性(Male);微RNAs(MicroRNAs);中年人(Middle Aged);预后(Prognosis);信号传导(Signal Transduction);存活率(Survival Rate);甲状腺(Thyroid Gland);甲状腺肿瘤(Thyroid Neoplasms)

DOI 10.1002/ijc.32622

PMID 31403184

发布时间 2020-03-13

检索历史清除

Hsa-miR-139-5p is a prognostic thyroid cancer marker involved in HNRNPF-mediated alternative splicing.

International journal of cancer

相似文献

同项目论文

International journal of cancer

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Hsa-miR-139-5p is a prognostic thyroid cancer marker involved in HNRNPF-mediated alternative splicing.

International journal of cancer

相似文献

同项目论文

International journal of cancer

相关期刊

检索历史清除